Epithelial membrane protein 2 controls VEGF expression in ARPE-19 cells

Area of Science:

• Ophthalmology
• Molecular Biology
• Cell Biology

Background:

• Vascular Endothelial Growth Factor (VEGF) production by retinal pigment epithelial (RPE) cells is crucial for regulating aberrant retinal angiogenesis.
• Epithelial Membrane Protein 2 (EMP2) is highly expressed in RPE cells and influences Focal Adhesion Kinase (FAK) activation, which is implicated in VEGF expression.

Purpose of the Study:

• To investigate whether EMP2 regulates VEGF expression in the ARPE-19 RPE cell line.

Main Methods:

• ARPE-19 cells were engineered for EMP2 overexpression and knockdown using siRNA.
• FAK activation was inhibited using the small molecule inhibitor PP2.
• VEGF levels were quantified via Western blot and ELISA.
• Functional assessment of secreted VEGF was performed using HUVEC migration assays.

Main Results:

• EMP2 overexpression led to a 150% increase in VEGF expression, while EMP2 knockdown decreased VEGF by 57%.
• Cell culture supernatants from EMP2-overexpressing cells significantly enhanced HUVEC migration and vessel tube formation.
• VEGF expression levels directly correlated with EMP2 levels.

Conclusions:

• A novel link between EMP2 and VEGF in RPE cells was established, potentially mediated by the tetraspanin web or FAK activation.
• This EMP2-VEGF connection is functionally significant, impacting angiogenesis.
• Modulation of EMP2 represents a potential therapeutic strategy for neovascularization in retinal diseases, complementing anti-VEGF therapies.